Mrs Katherine M Byra, MD in Jacksonville, FL - Pediatrics

Mrs Katherine M Byra, MD is a Pediatrics physician based in Jacksonville, Florida. Mrs Katherine M Byra is licensed to practice in Florida (license number ME116486) and her current practice location is 13241 Bartram Park Blvd, Suite # 209, Jacksonville, Florida. She can be reached at her office (for appointments etc.) via phone at (904) 242-4220.

NPI number for Mrs Katherine M Byra is 1033438502 and her current mailing address is 13241 Bartram Park Blvd, Suite # 209, Jacksonville, Florida. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1033438502.

Contact Information

	Mrs Katherine M Byra, MD
	13241 Bartram Park Blvd, Suite # 209, Jacksonville, FL 32258-5212
	(904) 242-4220
	(904) 551-1502

Physician's Profile

Full Name	Mrs Katherine M Byra
Gender	Female
Speciality	Pediatrics
Location	13241 Bartram Park Blvd, Jacksonville, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1033438502
Provider Enumeration Date: 05/24/2010
Last Update Date: 09/19/2022

Medical Identifiers

Medical identifiers for Mrs Katherine M Byra such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033438502	NPI	-	NPPES
010556400	Medicaid	FL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	ME116486 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Katherine M Byra is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Katherine M Byra, MD 13241 Bartram Park Blvd, Suite # 209, Jacksonville, FL 32258-5212 Ph: (904) 242-4220	Mrs Katherine M Byra, MD 13241 Bartram Park Blvd, Suite # 209, Jacksonville, FL 32258-5212 Ph: (904) 242-4220

News Archive

VeriStrat identifies NSCLC patients likely to respond to erlotinib

A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients.

ProtAffin signs manufacturing contract with CMC Biologics for COPD drug PA401

ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.

FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor

YM BioSciences Inc., announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration has granted Orphan Drug Designation to the Company's highly-selective JAK1/2 inhibitor, CYT387, for the treatment of myelofibrosis, a chronic debilitating unmet medical need, in which a patient's bone marrow is replaced by scar tissue, and for which treatment options are limited or unsatisfactory.

VaxGen signs definitive agreement to acquire diaDexus in stock-for-stock merger

VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.

Water from the Dead Sea, the climate of Jordan and a special cream can significantly help sufferers of vitiligo

Vitiligo causes the skin to lose its colour in patches and is associated with a build-up of an oxygen-related molecule (hydrogen peroxide) in the skin. Sufferers can't fight the development of this molecule due to a shortage of an enzyme in the skin.

Pediatrics Doctors in Jacksonville, FL

Dr. Maryam Ooja Abubakar, MD, MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 655 W 8th St, Jacksonville, FL 32209 Phone: 904-244-3508
Dr. Mohamad Alasad Tolaymat, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 820 Prudential Dr, Ufjp Pediatric Multi-specialty Clinic, Jacksonville, FL 32207 Phone: 904-633-0920 Fax: 904-633-0921
Christopher Emanuel, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3945 San Jose Park Dr, Jacksonville, FL 32217 Phone: 904-731-3530 Fax: 904-737-1548
Bridget Sharrar, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12276 San Jose Blvd Ste 507, Jacksonville, FL 32223 Phone: 904-288-8910 Fax: 904-288-8912
Kelly Marie Summers, ARNP Pediatrics Medicare: Medicare Enrolled Practice Location: 807 Childrens Way, Jacksonville, FL 32207 Phone: 904-697-3600
Yekaterina Jones, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 841 Prudential Dr Ste 1130, Jacksonville, FL 32207 Phone: 904-633-4199 Fax: 904-633-4188
Dr. Ronald P Carzoli Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1800 Barrs St, St Vincent's Medical Center, Jacksonville, FL 32204 Phone: 904-308-7994

Mrs Katherine M Byra, MD - Pediatrics in Jacksonville, FL